Nexalin Technology, INC S-1 registration statements

Nexalin Technology is filing an amendment to its Form S-1 registration statement to allow selling stockholders to resell up to 2,798,613 shares of common stock.

Nexalin Technology has filed an amendment to its S-1 registration statement to allow selling stockholders to resell up to 2,798,613 shares of common stock.

Nexalin Technology has filed an S-1 registration statement for the resale of up to 2,798,613 shares of common stock by selling stockholders, primarily related to warrants issued in connection with their 2022 public offering.

Nexalin Technology is seeking to raise up to $7 million by offering common stock at an assumed price of $2.26 per share, aiming to bolster its financial position and advance its neurostimulation technology.

Nexalin Technology is seeking to raise up to $7 million through a best-efforts offering of its common stock, aiming to fund general corporate purposes and advance its neurostimulation technology.

Nexalin Technology aims to raise up to $7 million through a common stock offering to fund general corporate purposes.

Nexalin Technology is offering up to $7 million of its common stock in a best effort offering to fund general corporate purposes.